EDGAR Filing Documents for 0001193125-17-268635

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-17-268635

Filing Date

2017-08-25

Accepted

2017-08-25 16:05:28

Documents

Effectiveness Date

2017-08-25

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d430321ds8.htm	S-8	47850
2	EX-5.1	d430321dex51.htm	EX-5.1	5025
3	EX-23.1	d430321dex231.htm	EX-23.1	1387
4	EX-99.1	d430321dex991.htm	EX-99.1	138292
5	GRAPHIC	g430321001.jpg	GRAPHIC	9379
	Complete submission text file	0001193125-17-268635.txt		206717

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-220170 | Film No.: 171052040
SIC: 2834 Pharmaceutical Preparations